Intriguingly, there is an increase in SNCA (alpha-synuclein) and p-SNCA in BaP-treated MRL mice, supporting a suspected link between autoimmune diseases and neurological disorders such as dementia [29]. This evidence concerns the gene SNCA and autoimmune disease.